XBI — State Street SPDR S&P Biotech ETF
State Street SPDR S&P Biotech ETF (ticker: XBI) is a equity ETF issued by State Street tracking S&P Biotechnology Select Industry. It was launched on 2006-01-31.
About XBI
The State Street SPDR S&P Biotech ETF (XBI) is an equity ETF that tracks the S&P Biotechnology Select Industry Index. It invests in companies within the biotechnology sector in North America. The fund utilizes an equal-weight strategy across its 157 holdings.
Investors might consider XBI for exposure to the U.S. biotechnology industry. It offers a diversified approach to the sector through its indexed, equal-weighted methodology.
- Tracks the S&P Biotechnology Select Industry Index.
- Invests in 157 biotechnology companies using an equal-weight strategy.
- Expense ratio of 0.35%.
- Average daily volume of 8,386,648.05.
- Total assets under management (AUM) of $8.31 billion.
Returns (Total Return)
| Period | Return |
|---|---|
| 1 Day | 1.62% |
| 1 Week | -3.44% |
| 1 Month | -0.45% |
| 3 Months | 5.13% |
| 6 Months | 6.57% |
| YTD | 6.48% |
| 1 Year | 57.73% |
| 3 Years | 50.52% |
| 5 Years | 2.63% |
| 10 Years | — |
| Since Inception | — |
Top Holdings
| # | Security | Symbol | Weight |
|---|---|---|---|
| 1 | OMNIAB INC 12.5 EARNOUT | 2200963D | — |
| 2 | US DOLLAR | N/A | — |
| 3 | US DOLLAR | N/A | — |
| 4 | OMNIAB INC 15.00 EARNOUT | 2200964D | — |
| 5 | OMNIAB INC 12.5 EARNOUT | 2200963D | — |
| 6 | OMNIAB INC 15.00 EARNOUT | 2200964D | — |
| 7 | US DOLLAR | N/A | — |
| 8 | OMNIAB INC 12.5 EARNOUT | 2200963D | — |
| 9 | OMNIAB INC 15.00 EARNOUT | 2200964D | — |
| 10 | OMNIAB INC 12.5 EARNOUT | 2200963D | — |
Fund Profile
| Issuer | State Street |
|---|---|
| Brand | State Street |
| Asset Class | equity |
| Strategy | Equal |
| Structure | ETF |
| Category | Health & Biotech Equities |
| Segment | Equity: U.S. Biotechnology |
| Sector | Biotechnology |
| Region | North America |
| Index Tracked | S&P Biotechnology Select Industry |
| Inception Date | 2006-01-31 |
| Tax on Distributions | Qualified dividends |
Quick Facts
| Ticker | XBI |
|---|---|
| Full Name | State Street SPDR S&P Biotech ETF |
| Issuer | State Street |
| Asset Class | equity |
| Expense Ratio | 0.00% |
| AUM | $7.78B |
| Inception | 2006-01-31 |
| Index Tracked | S&P Biotechnology Select Industry |
Frequently Asked Questions
What does XBI track?
XBI (State Street SPDR S&P Biotech ETF) tracks S&P Biotechnology Select Industry, a equity benchmark.
What is the expense ratio of XBI?
XBI has an expense ratio of 0.00% per year.
What is the AUM of XBI?
XBI has approximately $7.78B in assets under management.
Does XBI pay a dividend?
XBI distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.
Who issues XBI?
XBI is issued by State Street, launched on 2006-01-31.
Open the interactive XBI dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.